© Copyright Our Wall
As per Roots Analysis, in
order to overcome various challenges related to drug discovery, such as
preclinical failure rates, increased time period and heavy capital investments,
several pharmaceutical players are currently exploring the potential of quantum
computing in drug discovery processes.
The use of quantum
computingin drug
discovery is likely to improve the overall R&D productivity by providing
better clinical outcomes with accurate predictions of a drug molecule's
properties. Overall, this domain is anticipated to gain significant traction,
in the foreseen future. Presently, over 45 players around
the globe claim to offer quantum computing services across different steps of
drug discovery.
§
Drug
Discovery Service(s) Offered
§ Target Identification / Validation
§ Hit Generation / Lead Identification
§
Lead
Optimization
§
Therapeutic
Area
§ Cardiovascular Disorders
§ CNS Disorders
§ Dermatological Disorders
§ Endocrine Disorders
§ Gastrointestinal Disorders
§ Immunological Disorders
§ Infectious Diseases
§ Musculoskeletal Disorders
§ Oncological Disorders
§ Respiratory Disorders
§
Others
§
Geographical
Regions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America
§
MENA
The
“Quantum Computing in Drug DiscoveryServices Market 2023-2035” report
features the following companies, which we identified to be key players in this
domain:
§ Accenture
§ Amazon
Web Services
§ Atos
§ Fujitsu
§ Huawei
§ IBM
§ Microsoft
§ Xanadu
§ XtalPi
Table of Contents
1. Preface
2. Executive
Summary
3. Introduction
4. Market
Landscape: Quantum Computing SoftwareProviders
5. Company
Competitiveness Analysis
6. Company
Profiles: Software Providers
7. Market
Landscape: Hardware Providers
8. Company
Profiles: Hardware Providers
9. Academic
Grants Analysis
10. Partnerships
and Collaborations
11. Use
Case Study
12. Porter’s
Five Forces Analysis
13. Blue Ocean Strategy
14. Market
Sizing and Opportunity Analysis
15. Executive
Insights
16. Appendix
I- Tabulated Data
17 Appendix
II- List of Companies
To
view more details on this report, click on the link
https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html
News article
Global Cell Free
Expression Market
Learn
from experts: do you know about these
emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver
Therapeutic Modalities
mRNA Therapeutics and
mRNA Vaccines Industry: Current Scenario and Future Trends
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Learn more about Roots
Analysis consulting services:
Roots Analysis Consulting - the
preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
The “Digital Twins
Market: Industry Trends and Global Forecasts, 2022-2035” report features an
extensive study of the current landscape, offering an informed opinion on the
likely evolution of the market for such devices / services in the healthcare
domain, over the next decade.
The Digital Twin Marketreport features an in-depth
analysis, highlighting the capabilities of various stakeholders engaged in this
domain. The latest report also provides key
insights for Digital Twin
Technologyand Digital Twins Providers
Key Inclusions
§ A detailed
overview of the current market landscape of players engaged in the development
of digital twin, along with information on their
year of establishment, company size and location of headquarters. Further, it
highlights a detailed assessment of the overall market landscape of digital
twins in the healthcare domain, based on several relevant parameters, such as
status of development, therapeutic area, area(s) of application, type of
technology used, type of digital twin and end users.
§ An in-depth
analysis, highlighting the contemporary market trends, using five schematic
representations, including a stacked bar chart representation (based on area(s)
of application and status of development), a heat map representation (based on
type of technology used and type of digital twin), a grid representation (based
on type of end user and type of digital
twin), a bar chart representation
(based on area of application and
location of headquarters), a hybrid chart representation comparing the players
engaged in the digital twins in healthcare domain (based on company size and
location of headquarters).
§ An insightful
competitiveness analysis of players involved in the production / development of
digital twins in the healthcare domain, based on several relevant parameters,
such as years of experience, portfolio strength (in terms of number of
products, status of development, area(s) of application, technology used, end
user(s) and type of twin(s)), partnership strength and funding strength.
§ Elaborate profiles
of various prominent players that are currently engaged in the digital twins
domain. Each company profile features a brief overview of the company
(including information on its year of establishment, number of employees,
location of headquarters and key members of the executive team), details
related to its recent developments and an informed future outlook.
§ An insightful
analysis of the partnerships inked between various stakeholders, during the
period 2018-2022, covering acquisitions, mergers, development agreements,
technology integration agreements and technology utilization agreements.
§ An analysis of funding
and investments received by players engaged in digital twins domain, during the
period 2018-2022, including grants, debt, seed funding, venture series, initial
public offering, secondary offerings, private placements, private equity and
other equity.
§ A proprietary
analysis to evaluate start-ups engaged in this market space, by assigning
monetary values to various competition differentiators possessed by a player,
based on the Berkus start-up valuation parameters, including sound idea,
prototype, management experience and strategic relationships undertaken by
market players.
The report also features the likely distribution of
the current and forecasted opportunity across important market segments,
mentioned below:
§ Therapeutic Area
§ Type of Digital Twin
§ Area of Application
§ End Users
§ Key Geographical
Regions
Key Questions
Answered
§ Who are the
leading players engaged in the development of digital twins for the healthcare
domain?
§ Which type of
digital twin is most commonly offered by developers engaged in this market
space?
§ What is the
relative competitiveness of different players engaged in the digital twins
domain?
§ What is the likely
valuation of start-ups involved in the development of digital twins for the
healthcare sector?
§ What is the
present and likely future demand for digital twins in the overall healthcare
sector?
§ What are the
anticipated future trends related to digital twins in the healthcare domain?
§ How is the current
and future opportunity likely to be distributed across key market segments?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-twins-market.html
You may also be interested in the following titles:
Decentralized
Clinical Trials / Virtual Clinical Trials Market
mRNA
Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Digital
Biomanufacturing Market
Roots Analysis
Consulting - the preferred research partner for global firms
About Roots
Analysis
Roots
Analysis is a global leader in the pharma / biotech market
research. Having worked with over 750 clients worldwide, including Fortune 500
companies, start-ups, academia, venture capitalists and strategic investors for
more than a decade, we offer a highly analytical / data-driven perspective to a
network of over 450,000 senior industry stakeholders looking for credible
market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
CAR-T cell
therapies have been shown to enable complete disease remission, omitting the
need for any further treatment. Several studies have proven the efficacy of
these therapy candidates.
Driven by the
ongoing pace of innovation and sufficient financial support from investors, the
CAR-T cell therapy market is anticipated to witness substantial growth in the
foreseen future
The financial opportunity within the CAR T cell therapy markethas been analyzed across the following segments:
§ Target Indication(s)
§ Non-Hodgkin’s Lymphoma
§ Multiple Myeloma
§ Acute Lymphoblastic Leukemia
§ Chronic Lymphocytic Leukemia
§ Hodgkin’s Lymphoma
§ Acute Myeloid Leukemia
§ Ovarian Cancer
§ Generalized Myasthenia Gravis (MG)
§ Renal Cell Carcinoma
§ Target Antigen
§ CD19
§ BCMA
§ CD19/22
§ Others
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
§ Latin America
§ Middle East and North
Africa
§ Rest of the World
The
Global CAR-T Cell TherapyMarket (4th
Edition), 2022-2035report features the following companies, which we identified to be key players
in this domain:
§ Autolus
§ bluebird Bio
§ Bristol Myers Squibb
§ Carsgen Therapeutics
§ Cellectis
§ Cellular Biomedicine Group
§ Gilead Sciences
§ Innovative Cellular Therapeutics
§ Kuur Therapeutics
§ Noile-Immune Biotech
§ Novartis
§ Shanghai GeneChem
§ Sinobioway Cell Therapy
§ Takara Bio
§ Wellington Zhaotai Therapies
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. CAR T Cell Therapies: Market Landscape
5. Key
Insights
6. Clinical
Trial ANALYSIS
7. Key
Opinion Leaders
8. CAR-T
Cell Therapy Profiles
9. Partnerships
And Collaborations
10. Funding
And Investment Analysis
11. Patent
Analysis
12. Case
Study: Cell Therapy Manufacturing
13. Cost
Price Analysis
14. Market
Forecast and Opportunity Analysis
15. Promotional
Analysis
16. Company
Profiles
17. Concluding
Remarks
18. Executive
Insights
19. Appendix
1: Tabulated Data
20. Appendix 2: List of Companies and
Organizations
Get
more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
You may also be interested in the following titles:
Antiviral
Drugs: The Unmet Requirement in the Pharmaceutical Space
Smart
Pharmaceutical and Healthcare Labels Market
Roots Analysis
Consulting - the preferred research partner for global firms
About Roots
Analysis
Roots
Analysis is a global leader in the pharma / biotech market research.
Having worked with over 750 clients worldwide, including Fortune 500 companies,
start-ups, academia, venture capitalists and strategic investors for more than
a decade, we offer a highly analytical / data-driven perspective to a network
of over 450,000 senior industry stakeholders looking for credible market
insights.
Contact:
Ben Johnson
+1 (415) 800 3415